About UW Carbone Cancer Center

The UW Carbone Cancer Center (UWCCC) holds the unique distinction of being the only comprehensive cancer center in Wisconsin, as designated by the National Dr. Howard Bailey UWCCC DirectorCancer Institute, the lead federal agency for cancer research. Every day on the UW-Madison campus, thousands of dedicated individuals work meticulously to find the best ways to prevent, detect, diagnose and treat cancer.


An integral part of the UW School of Medicine and Public Health, the UWCCC unites physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients.

More than 30,000 people are seen annually for diagnosis, therapy, follow-up care or consultations at UW Hospital and Clinics, as well as our other clinical locations.


Dr. Howard Bailey has been named Director of the UW Carbone Cancer Center.


The UWCCC leadership includes:

  • Howard Bailey, Director
  • Peter Connor, Associate Director of Administration
  • Paul Ahlquist, Associate Director of Basic Science
  • Amy Trentham-Dietz, Associate Director of Cancer Control Research
  • Ruth O'Regan, Associate Director of Clinical Research
  • Bill Sugden, Associate Director of Faculty Development and Education
  • Umberto Tachinardi, Associate Director of Informatics
  • James Shull, Associate Director of Laboratory Research
  • David Jarrard, Associate Director of Translational Research
  • Daniel Mulkerin, Medical Director, Oncology Services
  • Sharon Weber, Medical Director, Surgical Oncology

Leading Achievements

  • Developed an immunotherapy improving neuroblastoma outcomes by 50%
  • Developed tomotherapy - a specialized form of radiation therapy targeting cancer cells, avoiding other cells and organs
  • Instrumental in Wisconsin law improving patient access to clinical trials
  • Leading developer of virtual colonoscopy
  • Two $7 million federal grants received to fund housing for interdisciplinary prostate and breast cancer research
  • Established a palliative care unit at UW Hospital and Clinics
  • Chosen to lead a national consortium of five institutions to conduct multiple Phase I and II clinical trials of cancer chemopreventive agents
  • Developed tamoxifen, one of the best therapies for treating and preventing breast cancer
  • Introduced 5-flourouracil, widely used to treat breast, ovarian, stomach and colon cancers
  • Developed the conceptual basis for combination drug therapy
  • Led the first clinical trials with DFMO, a potential cancer-preventing agent that slows an enzyme involved in tumor growth
  • Nobel prize for elucidating the basis of viral carcinogenesis
  • Sponsored the nation's first telephone-based cancer helpline, which has now become the National Cancer Institute's Cancer Information Service
  • First radiation oncology department in country to have CT/PET scanning for treatment planning
  • Led the development of the Wisconsin Cancer Council and Wisconsin Cancer Pain Initiative

Learn more about the UWCCC: